QTRX (Quanterix Corporation) Stock Financials & Earnings

QTRXQuanterix Corporation

Mkt Cap$239M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$139M

Net Income (TTM)-$107M

EPS (TTM)-$2.52

Free Cash Flow (TTM)-$80M

Gross Margin46.7%

Op. Margin-90.5%

Net Margin-77.2%

FCF Margin-57.6%

P/S Ratio (TTM)1.7x

P/E Ratio (TTM)—

YoY Rev Growth+2.4%

Employees—

Earnings Reports

▶Q4 2025NEW

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North...

CEO Everett V. CunninghamIPO Dec 7, 2017www.quanterix.com

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$28M	$17M	-$9M
Q2 23	$31M	$19M	-$10M
Q3 23	$31M	$19M	-$13M
Q4 23	$31M	$16M	-$17M
Q1 24	$32M	$18M	-$15M
Q2 24	$34M	$22M	-$11M
Q3 24	$35M	$20M	-$12M
Q4 24	$34M	$21M	-$15M
Q1 25	$30M	$16M	-$26M
Q2 25	$24M	$11M	-$37M
Q3 25	$40M	$17M	-$37M
Q4 25	$44M	$20M	-$25M

Valuation

Quarter	P/S	P/E
Q1 23	4.0x	—
Q2 23	7.4x	—
Q3 23	8.7x	—
Q4 23	8.2x	—
Q1 24	7.3x	—
Q2 24	3.8x	—
Q3 24	3.8x	—
Q4 24	3.1x	—
Q1 25	1.9x	—
Q2 25	2.1x	—
Q3 25	1.6x	—
Q4 25	2.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$10M	-$10M
Q2 23	$633K	-$15K
Q3 23	-$4M	-$5M
Q4 23	-$6M	-$8M
Q1 24	-$20M	-$21M
Q2 24	-$5M	-$7M
Q3 24	-$6M	-$7M
Q4 24	-$4M	-$5M
Q1 25	-$14M	-$15M
Q2 25	-$6M	-$6M
Q3 25	-$41M	-$42M
Q4 25	-$16M	-$16M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$136K
Q2 23	$648K
Q3 23	$788K
Q4 23	$2M
Q1 24	$506K
Q2 24	$2M
Q3 24	$851K
Q4 24	$412K
Q1 25	$1M
Q2 25	$777K
Q3 25	$677K
Q4 25	$98K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	-4.5%	-21.1%
Q2 23	+31.8%	-16.4%
Q3 23	+17.8%	-30.3%
Q4 23	+21.8%	+1.2%
Q1 24	+12.6%	+24.7%
Q2 24	+10.5%	+11.5%
Q3 24	+14.0%	+7.5%
Q4 24	+9.3%	+1.5%
Q1 25	-4.8%	+20.6%
Q2 25	-28.3%	+36.6%
Q3 25	+13.4%	+64.3%
Q4 25	+28.6%	+40.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$4M	13.8%
Q2 23	$4M	13.6%
Q3 23	$4M	14.0%
Q4 23	$0	0.0%
Q1 24	$0	0.0%
Q2 24	$0	0.0%
Q3 24	$0	0.0%
Q4 24	$0	0.0%
Q1 25	$5M	18.0%
Q2 25	$5M	22.0%
Q3 25	$0	0.0%
Q4 25	$4M	10.1%

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 23	$5M	$22M	—
Q2 23	$6M	$23M	—
Q3 23	$8M	$24M	—
Q4 23	$7M	$25M	—
Q1 24	$7M	$27M	—
Q2 24	$8M	$25M	—
Q3 24	$8M	$24M	—
Q4 24	$8M	$29M	—
Q1 25	$10M	$33M	—
Q2 25	$9M	$32M	—
Q3 25	$8M	$39M	—
Q4 25	$9M	—	$35M

Revenue Segments

Quarter	License and Service	Product	Service And Other Revenue
Q4 25	$152K	$29M	$14M

Revenue by Geography

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$329M	$0	$329M
Q2 23	$330M	$0	$330M
Q3 23	$201M	$126M	$328M
Q4 23	$174M	$147M	$321M
Q1 24	$45M	$257M	$302M
Q2 24	$47M	$250M	$297M
Q3 24	$29M	$264M	$294M
Q4 24	$57M	$232M	$289M
Q1 25	$77M	$190M	$267M
Q2 25	$133M	$128M	$261M
Q3 25	$38M	$97M	$135M
Q4 25	$30M	$88M	$118M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	37M	+0.4%
Q2 23	37M	+0.4%
Q3 23	38M	+0.4%
Q4 23	38M	+0.6%
Q1 24	38M	+0.6%
Q2 24	38M	+0.6%
Q3 24	38M	+0.3%
Q4 24	39M	+0.3%
Q1 25	39M	+0.4%
Q2 25	39M	+0.5%
Q3 25	46M	+18.4%
Q4 25	47M	+1.6%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 15	—	—
FY 16	—	—
FY 17	$182K	126
FY 18	$213K	177
FY 19	$229K	248
FY 20	$275K	314
FY 21	$240K	460
FY 22	$844K	125
FY 23	$859K	141
FY 24	$288K	471
FY 25	$309K	450